Recent Statistics
Explore the latest published and updated statistics across all industries and topics
Australia Biosimilars Market Size Forecast (2024–2032)
Explore Australia’s biosimilars outlook, at USD 275.26 Mn in 2024 and projected to reach USD 675.44 Mn by 2032, driven by rising uptake and cost-efficient use.
Japan Biosimilars Market Market Size from 2024 to 2032
Analyse Japan’s biosimilars sector, at USD 760.19 Mn in 2024 and projected to reach USD 2,076.01 Mn by 2032, supported by diversified demand and cost focus.
China Biosimilars Market Size Forecast (2024–2032)
Discover China’s biosimilars market, valued at USD 1,621.45 Mn in 2024 and projected to reach USD 5,136.21 Mn by 2032, driven by large-scale manufacturing.
Germany Biosimilars Market Revenue Growth (2024–2032)
Analyse Germany’s biosimilars market, at USD 2,020.58 Mn in 2024 and projected to reach USD 5,371.24 Mn by 2032, supported by strong regulation and adoption.
Mexico Biosimilars Market Market Size from 2024 to 2032
Explore Mexico’s biosimilars landscape, valued at USD 775.15 Mn in 2024 and projected to reach USD 1,778.13 Mn by 2032, driven by affordability and uptake.
Russia Biosimilars Market Size Forecast (2024–2032)
Analyse Russia’s biosimilars market, at USD 787.74 Mn in 2024 and projected to reach USD 1,879.15 Mn by 2032, supported by expanding domestic manufacturing.
France Biosimilars Market Size from 2024 to 2032
Explore France’s biosimilar market, valued at USD 1,569.97 Mn in 2024 and projected to reach USD 3,994.02 Mn by 2032, driven by strong formulary support.
U.S. Biosimilars Market Revenue Outlook (2024–2032)
Discover U.S. Biosimilars market insights, where the market recorded 11940.74 USD Mn in 2024 and is projected to reach 29868.93 USD Mn in 2032, driven by strong therapeutic adoption.
Asia Pacific Biosimilars Market Analysis: China vs S.Korea (2024–2032)
China led the Asia Pacific Biosimilars Market in 2024 at USD 1,621.45 million and is projected to hit USD 5,136.21 million by 2032, overtaking South Korea through broader manufacturing scale.
Global Biosimilars Market Share, by Country (2025)
Explore Global Biosimilars Market; North America leads with 42.06% in 2025, projected to maintain a high share by 2032 due to advanced healthcare systems.
Europe Biosimilars Market Share, by Country (2025)
Discover Europe Biosimilars Market; Italy dominates with 21.23% in 2025, projected to retain lead till 2032 due to advanced healthcare and regulatory support.
South America Biosimilars Market Share, by Country (2025)
Explore South America Biosimilars Market; Brazil leads with 46.20% in 2025, expected to dominate till 2032 due to strong market infrastructure and biosimilar adoption.
MEA Biosimilars Market Share, by Country (2025)
Discover MEA Biosimilars Market; GCC leads with 39.28% in 2025, expected to dominate through 2032 due to high healthcare investment and biologics access.
Asia Pacific Biosimilars Market Share, by Country (2025)
Explore the Asia Pacific Biosimilars Market; China dominates with 30.53% in 2025, projected to maintain a high share by 2032 due to strong regulatory support.
Global Biosimilars Market size: NA vs Europe Comparison (2024–2032)
Discover global regional shifts: North America led with USD 13,991.97 Mn in 2024 and dominates at USD 34,335.12 Mn in 2032 owing to broader approvals and large healthcare spend.
South America Biosimilars Market Size, by Country (2024–2032)
Explore South America biosimilars Market: Brazil recorded USD 478.10 Mn in 2024, driven by expanded payer programs and local manufacturing scaled access.
MEA Biosimilars Market Size, by Country (2024–2032)
Analyse MEA biosimilars Market trends: GCC led in 2024 and projected to reach USD 1,557.58 Mn by 2032 due to healthcare investments and procurement programs.
Asia Pacific Biosimilars Market Size, by Country (2024–2032)
Discover Asia Pacific biosimilars Market: China recorded USD 1,621.45 Mn in 2024 due to scale, manufacturing capacity, and policy support.
Europe Biosimilars Market Size, by Country (2024–2032)
Explore Europe biosimilars Market: France led with USD 1,569.97 Mn in 2024, while Italy is projected to dominate at USD 6,769.25 Mn in 2032 due to expanded therapeutic portfolios.
North America Biosimilars Market Size, by Country (2024–2032)
Explore North America's biosimilars surge, with the United States projected to reach USD 29,868.93 million by 2032, driven by high therapeutic adoption.
Global Biosimilars Market Size, by Region (2024–2032)
Global Biosimilars Market is expected to reach USD 34,335.12 Mn in North America and USD 15,443.21 Mn in Asia Pacific by 2032, driving regional growth and innovation.
Global Biosimilars Market Size & YoY Growth (2024–2032)
Global Biosimilars Market to reach USD 84,069.34 Mn by 2032, with strong YoY growth of 14.82%, driving innovation, patient access, and market value.